kits and reagents segment dominated the market with its largest revenue share contribution, owing to
the increasing use of consumables for mycoplasma analysis while conducting cell culture research work and related activities.
In terms of technology, the
Polymerase Chain Reaction (PCR) segment held the majority of the market share and is expected to constitute more than half of the market over the forecast period.
High specificity, efficiency, and preciseness are some of the key attributes that make PCR ideal for mycoplasma analysis.
Pharmaceutical & biotechnology companies market segment accounted for over 25% of the
revenue share in 2019 owing to the growing demand for mycoplasma testing for cell culture research and several research & development activities
Mycoplasma Testing Market May See a Big Move : Major Giants InvivoGen, PromoCell, Lonza Group
Edison, NJ (SBWIRE) 12/23/2020 Global Mycoplasma Testing Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, players market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions. According to AMA, the Global Mycoplasma Testing market is expected to see growth rate of 12.5% and may see market size of USD1.19 Billion by 2024.